If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKAPE.L Regulatory News (KAPE)

  • There is currently no data for KAPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - KAPE LN

21 Apr 2023 15:00

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Sand Grove Capital Management LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Fund(s) for which Sand Grove Capital Management LLP serves as the Investment Manager or Discretionary Sub-Advisor

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Kape Technologies Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

20 April 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

USD0.0001 ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

13,304,676

3.10%

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

13,304,676

3.10%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

USD0.0001 ordinary

Purchase

1,750,000

3.5776 USD

USD0.0001 ordinary

Purchase

85,000

3.5800 USD

USD0.0001 ordinary

Purchase

214,163

3.5785 USD

USD0.0001 ordinary

Purchase

365,421

3.5794 USD

USD0.0001 ordinary

Purchase

12,500

3.5781 USD

USD0.0001 ordinary

Purchase

433,333

3.5800 USD

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

No

Date of disclosure:

21 April 2023

Contact name:

Daniel Mclachlan

Telephone number:

+44 203 770 8617

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230421005213/en/

Copyright Business Wire 2023

Date   Source Headline
18th May 20177:00 amRNSAGM Statement
24th Apr 20177:00 amRNSPosting of Annual Report and Notice of AGM
14th Mar 20177:00 amRNSFinal Results
14th Mar 20177:00 amRNSAcquisition
10th Mar 20177:00 amRNSBlocklisting Return
6th Feb 20172:00 pmRNSBoard Appointment
17th Jan 20177:00 amRNSTrading Update and Notice of Results
29th Nov 20164:47 pmRNSHolding(s) in Company
28th Oct 20167:00 amRNSCEO & CFO Purchase of Shares & Holdings in Company
27th Oct 20168:15 amRNSAppointment of Chief Financial Officer
24th Oct 20167:00 amRNSAcquisition
30th Sep 20165:08 pmRNSTotal Voting Rights
20th Sep 20164:40 pmRNSSecond Price Monitoring Extn
20th Sep 20164:35 pmRNSPrice Monitoring Extension
20th Sep 20167:00 amRNSHalf-year Report
12th Sep 20167:00 amRNSBlocklisting Return
19th Aug 20167:00 amRNSAppointment of Acting Chief Financial Officer
17th Aug 20164:05 pmRNSTermination of option agreement
26th Jul 20169:01 amRNSTrading Update
26th Jul 20167:00 amRNSNotice of Results
1st Jun 20167:00 amRNSIssue of equity share options
31st May 20167:00 amRNSBoard Changes including appointment of CEO
19th May 20161:32 pmRNSResult of AGM
17th May 20167:00 amRNSTrading Update
21st Apr 20164:00 pmRNSNotice of AGM
15th Mar 20167:00 amRNSFinal results for the year ended 31 December 2015
10th Mar 20169:52 amRNSBlocklisting Return
1st Feb 20167:00 amRNSTrading Update
8th Jan 20167:00 amRNSHolding(s) in Company
8th Jan 20167:00 amRNSTransaction in Own Shares
31st Dec 201511:01 amRNSTotal Voting Rights
21st Dec 20157:00 amRNSHolding(s) in Company
21st Dec 20157:00 amRNSTransaction in Own Shares
11th Dec 20157:00 amRNSTransaction in Own Shares
2nd Dec 20157:00 amRNSTransaction in Own Shares
1st Dec 201512:06 pmRNSTotal Voting Rights
23rd Nov 20157:00 amRNSHolding(s) in Company
20th Nov 20157:00 amRNSTransaction in own shares
19th Nov 20157:00 amRNSShare Buyback Programme
10th Sep 20154:40 pmRNSSecond Price Monitoring Extn
10th Sep 20154:35 pmRNSPrice Monitoring Extension
8th Sep 20159:00 amRNSBlocklisting Application
8th Sep 20157:00 amRNSHalf Yearly Report
23rd Jul 20157:00 amRNSTrading Statement
23rd Jun 20157:00 amRNSCapital Markets Event
19th May 20151:00 pmRNSResult of AGM
15th Apr 201511:18 amRNSNotice of AGM
23rd Mar 20157:00 amRNSCEO Purchase of Shares and Holdings in Company
20th Mar 20153:23 pmRNSAnnual Financial Report
10th Mar 20157:03 amRNSPreliminary Resuts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.